Pediatric Hypertension: (Clinical Hypertension & Vascular Diseases) is a specialized medical reference that addresses the growing recognition of high blood pressure in children and adolescents. As part of the respected Clinical Hypertension & Vascular Diseases series, this volume provides a comprehensive, evidence-based overview of the epidemiology, pathophysiology, diagnosis, and management of hypertension in the pediatric population. Designed for pediatricians, nephrologists, cardiologists, family physicians, and trainees, the book bridges the gap between adult hypertension research and the unique clinical challenges presented by younger patients.
Over the past few decades, pediatric hypertension has emerged as a significant public health concern. Once considered rare and usually secondary to renal or endocrine disorders, hypertension in children is now increasingly linked to primary (essential) causes, largely driven by the global rise in childhood obesity. This book highlights how early-life blood pressure abnormalities can track into adulthood, predisposing individuals to cardiovascular disease, stroke, and kidney failure later in life. By emphasizing early identification and intervention, the text reinforces the importance of preventive cardiology beginning in childhood.
The book begins with foundational chapters on blood pressure physiology in infants, children, and adolescents. It explains age-specific norms and the complexity of interpreting blood pressure in pediatric patients, where percentiles based on age, sex, and height are used instead of fixed adult thresholds. Detailed guidance is provided on proper blood pressure measurement techniques, including office-based readings, ambulatory blood pressure monitoring (ABPM), and home monitoring. The role of ABPM in detecting white coat hypertension and masked hypertension is thoroughly discussed, reflecting current best practices.
A significant portion of the text is devoted to the causes of pediatric hypertension. Secondary hypertension remains more common in younger children and is often related to renal parenchymal disease, renovascular abnormalities, coarctation of the aorta, or endocrine disorders such as hyperthyroidism and pheochromocytoma. The book outlines systematic diagnostic approaches, including laboratory testing, imaging modalities, and specialized evaluations to identify underlying etiologies. Clear algorithms help clinicians determine when extensive workups are warranted.
Primary hypertension, increasingly seen in adolescents, is examined in depth. The authors explore contributing factors such as obesity, insulin resistance, sedentary lifestyle, dietary sodium excess, and genetic predisposition. The interplay between metabolic syndrome and hypertension is analyzed, emphasizing how clustering of cardiovascular risk factors begins early in life. The text integrates current research on vascular biology, inflammation, and endothelial dysfunction, offering insight into early vascular damage in hypertensive youth.
Target organ damage in pediatric hypertension is another critical theme. The book reviews evidence of left ventricular hypertrophy, microalbuminuria, carotid intima-media thickness, and retinal changes in children with sustained high blood pressure. It underscores the importance of echocardiography and renal assessment in monitoring long-term impact. By documenting subclinical organ damage, clinicians are better equipped to stratify risk and tailor treatment strategies.
Management strategies are presented in a stepwise, practical manner. Non-pharmacologic therapy is emphasized as first-line treatment for most children with primary hypertension. Lifestyle interventions include weight management, increased physical activity, reduced sodium intake, balanced nutrition, and limitation of screen time. The book provides counseling strategies for families, recognizing that behavioral change requires a supportive home and community environment.
When pharmacologic treatment is necessary, the text offers detailed guidance on medication selection, dosing, monitoring, and safety considerations. Drug classes commonly used in children—such as ACE inhibitors, angiotensin receptor blockers, calcium channel blockers, beta-blockers, and diuretics—are reviewed with attention to pediatric-specific evidence and side-effect profiles. Special populations, including children with chronic kidney disease, diabetes, or congenital heart disease, receive focused discussion to guide individualized therapy.
The book also addresses hypertension in neonates and critically ill children, an area often underrepresented in general pediatric texts. It examines blood pressure regulation in premature infants and discusses management in neonatal intensive care settings. Additionally, chapters on hypertension related to systemic diseases and genetic syndromes broaden the clinical scope.
A forward-looking perspective is provided through discussions of emerging research, biomarkers, and long-term outcome studies. The authors emphasize the need for population-based screening programs, improved public health policies, and interdisciplinary collaboration. By connecting clinical care with preventive strategies, the book highlights how early intervention can alter the trajectory of cardiovascular disease across the lifespan.
In summary, Pediatric Hypertension: (Clinical Hypertension & Vascular Diseases) is a thorough and authoritative resource dedicated to understanding and managing high blood pressure in children and adolescents. Combining scientific depth with practical clinical guidance, it equips healthcare professionals with the tools necessary to diagnose accurately, treat effectively, and ultimately reduce the burden of cardiovascular disease beginning in childhood.

Reviews
There are no reviews yet